NAVIDEA BIOPHARMACEUTICALS I (NAVB)
US63937X2027 - Common Stock
Navidea Biopharmaceuticals, Inc. Announces Results of Exploratory Analysis Completed on July 2, 2024
Navidea Biopharmaceuticals, Inc. announces special meeting of stockholders to be held July 8, 2024
Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations
Navidea settles litigation with Capital Royalty, stock rallies 30% (NAVB)
Navidea Biopharmaceuticals (NAVB) and Capital Royalty Partners have entered into a binding agreement and mutual release to settle their long-running litigation. Read more here.
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
Navidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common Stock
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are a hot topic on Tuesday as investors seek out the latest news on the biggest traders this morning!
Navidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing Panel
Why Is SOFI Stock Up 19% Today?
SoFi Technologies (SOFI) stock is on the rise Monday after the financial services company released results for the second quarter of 2023!
Navidea Biopharmaceuticals, Inc. Presses Ahead, Embraces Opportunities
Why Is Sonnet BioTherapeutics (SONN) Stock Down 5% Today?
Sonnet BioTherapeutics (SONN) stock is taking a beating on Monday after the company announced details for a public stock offering.
Why Is Navidea Biopharmaceutical (NAVB) Stock Down 13% Today?
Navidea Biopharmaceutical (NAVB) stock is falling on Monday after the biopharmaceutical company got a major delisting warning.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start off the week with a breakdown of the biggest pre-market stock movers worth watching for Monday morning!
Navidea Biopharmaceuticals, Inc. Announces NYSE American Has Commenced Delisting Proceedings and Intent to Appeal NYSE American Determination
Navidea Biopharmaceuticals hires Craig Dais as CFO (NYSE:NAVB)
Navidea Biopharmaceuticals (NAVB) on Thursday said it had named Craig Dais as its CFO. Read more here.
Navidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA as Chief Financial Officer
Navidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to Board of Directors; Amit Bhalla Steps Down
Navidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer To Acquire Certain Assets
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to start off the day with a breakdown of the biggest pre-market stock movers worth watching on Wednesday morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time for another dive into the biggest pre-market stock movers as we check out all the latest news for Tuesday morning!
